ArticleJSES international2025
Minimum 10-year outcomes after arthroscopically assisted anatomic coracoclavicular ligament reconstruction for the treatment of type III and V acromioclavicular joint injuries.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advantages and Disadvantages of the Arthroscopic Procedure in Acromioclavicular Separation.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acromioclavicular joint (ACJ) injuries can lead to severe pain and reduced shoulder function. Anatomic coracoclavicular ligament reconstruction (ACCR) using a free tendon graft has demonstrated favorable biomechanical properties and good short- to mid-term outcomes, but data on long-term outcomes are scarce. The purpose of the present study was to evaluate the long-term clinical and functional outcomes after ACCR with a focus on return to sport and revision surgery. Methods: Patients who underwent ACCR using a free tendon allograft for the treatment of ACJ injuries type III or V between November 2006 and April 2011 by a single surgeon, with a minimum 10-year follow-up, were eligible for inclusion. Patient-reported outcome measures, including the American Shoulder and Elbow Surgeons score, short version of the Disabilities of the Arm, Shoulder and Hand questionnaire, Single Assessment Numeric Evaluation, patient satisfaction (1-10 scale with "10" indicating maximum satisfaction), rates of return to sport and revision surgery were evaluated minimum 10 years postoperatively. Pain (via visual analog scale) was assessed preoperatively and at final follow-up. Patients who underwent further surgery were excluded from analysis. Survivorship was reported as two scenarios: not undergoing revision ACJ stabilization and not undergoing any further surgery. Results: Fourteen patients were evaluated after 13.0 (interquartile range, 12.0-15.0) years. Four patients (28.6%) underwent further surgery (revision ACJ stabilization [n = 2], exostosis removal [n = 2]) and were excluded from further analysis. Shoulder function was excellent at follow-up (American Shoulder and Elbow Surgeons score: 100 [96.6-100], Quick Disabilities of the Arm, Shoulder and Hand: 0 [0-5.1]), Single Assessment Numeric Evaluation: 99.0 [91.5-99.0]). Pain levels decreased significantly from preoperatively to follow-up (visual analog scale for pain: 2.0 [1.0-3.0] to 0 [0-0.5], Conclusion: ACCR using a free tendon graft for the treatment of ACJ injuries type III or V resulted in good to excellent shoulder function, low pain levels, and high patient satisfaction at long-term follow-up. The rate of revision ACJ stabilization was 14.3%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.